L-Alloisoleucine

Common Name

L-Alloisoleucine Description

L-alloisoleucine is a branched chain amino acid and is a stereo-isomer of L-isoleucine. It is a common constituent of human plasma (albeit at low levels). L-alloisoleucine is produced as a byproduct of isoleucine transamination. L-Isoleucine is one of the four common amino acids (the 3 others being threonine, hydroxyproline, and hydroxylysine) that have two asymmetric carbon atoms which produce four structural possibilities for the same chemical composition. L-alloisoleucine differs from L-isoleucine by having having different stereochemistry around its beta carbon. Plasma L-alloisoleucine, which is derived from L-isoleucine in vivo, can be used for the diagnosis of maple syrup urine disease (MSUD). Indeed, plasma L-alloisoleucine levels above 5 umol/L is the most specific and most sensitive diagnostic marker for all forms of MSUD (PMID: 10508118 ). In MSUD the degradation of the essential branched-chain L-amino acids leucine, valine, and isoleucine and their derived 2-oxoacids is impaired because of an inherited deficiency in branched-chain 2-oxoacid dehydrogenase complex (EC 1.2.4.4) activity. The accumliation of branched-chain compounds in blood and other body fluids can exert neurotoxic effects. Structure

Synonyms

Value Source (2S,3R)-2-amino-3-Methylpentanoic acidChEBI AlleChEBI allo-L-IsoleucineChEBI L(+)-AlloisoleucineChEBI threo-3-Methyl-L-norvalineChEBI threo-L-IsoleucineChEBI (2S,3R)-2-amino-3-MethylpentanoateGenerator (3R)-LS-IsoleucineHMDB 2-amino-3-Methyl-[S-(r*,s*)]-pentanoateHMDB 2-amino-3-Methyl-[S-(r*,s*)]-pentanoic acidHMDB allo-IsoleucineHMDB L-allo-IsoleucineHMDB [S-(R*,s*)]-2-amino-3-methylpentanoateHMDB [S-(R*,s*)]-2-amino-3-methylpentanoic acidHMDB AlloisoleucineMeSH Isoleucine, L isomerMeSH Isoleucine, L-isomerMeSH L-Isomer isoleucineMeSH L-IsoleucineMeSH IsoleucineMeSH

Chemical Formlia

C6H13NO2 Average Molecliar Weight

131.1729 Monoisotopic Molecliar Weight

131.094628665 IUPAC Name

(2S,3R)-2-amino-3-methylpentanoic acid Traditional Name

allo-isoleucine CAS Registry Number

1509-34-8 SMILES

CC[C@@H](C)[C@H](N)C(O)=O

InChI Identifier

InChI=1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5+/m1/s1

InChI Key

AGPKZVBTJJNPAG-UHNVWZDZSA-N Chemical Taxonomy Description

This compound belongs to the class of chemical entities known as isoleucine and derivatives. These are compounds containing isoleucine or a derivative thereof resliting from reaction of isoleucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Kingdom

Chemical entities Super Class

Organic compounds Class

Organic acids and derivatives Sub Class

Carboxylic acids and derivatives Direct Parent

Isoleucine and derivatives Alternative Parents

  • L-alpha-amino acids
  • Methyl-branched fatty acids
  • Amino acids
  • Monocarboxylic acids and derivatives
  • Carboxylic acids
  • Organopnictogen compounds
  • Organic oxides
  • Monoalkylamines
  • Hydrocarbon derivatives
  • Carbonyl compounds
  • Substituents

  • Isoleucine or derivatives
  • Alpha-amino acid
  • L-alpha-amino acid
  • Branched fatty acid
  • Methyl-branched fatty acid
  • Fatty acid
  • Fatty acyl
  • Amino acid
  • Monocarboxylic acid or derivatives
  • Carboxylic acid
  • Organic oxide
  • Organopnictogen compound
  • Primary amine
  • Organooxygen compound
  • Organonitrogen compound
  • Primary aliphatic amine
  • Carbonyl group
  • Organic oxygen compound
  • Amine
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Aliphatic acyclic compound
  • Molecliar Framework

    Aliphatic acyclic compounds External Descriptors

  • non-proteinogenic L-alpha-amino acid (CHEBI:43433 )
  • alloisoleucine (CHEBI:43433 )
  • Ontology Status

    Detected and Quantified Origin

  • Endogenous
  • Biofunction

    Not Available Application

    Not Available Cellliar locations

  • Cytoplasm
  • Physical Properties State

    Solid Experimental Properties

    Property Value Reference Melting Point60 – 64 °CNot Available Boiling PointNot AvailableNot Available Water Solubility34.4 mg/mL at 25 °CNot Available LogP-1.70HANSCH,C ET AL. (1995)

    Predicted Properties

    Property Value Source Water Solubility114.0 mg/mLALOGPS logP-1.7ALOGPS logP-1.5ChemAxon logS-0.06ALOGPS pKa (Strongest Acidic)2.79ChemAxon pKa (Strongest Basic)9.59ChemAxon Physiological Charge0ChemAxon Hydrogen Acceptor Count3ChemAxon Hydrogen Donor Count2ChemAxon Polar Surface Area63.32 Å2ChemAxon Rotatable Bond Count3ChemAxon Refractivity34.09 m3·mol-1ChemAxon Polarizability14.23 Å3ChemAxon Number of Rings0ChemAxon Bioavailability1ChemAxon Rlie of FiveYesChemAxon Ghose FilterYesChemAxon Vebers RlieYesChemAxon MDDR-like RlieYesChemAxon

    Spectra Spectra

    Spectrum Type Description Splash Key LC-MS/MS

    LC-MS/MS Spectrum – Quattro_QQQ 10V, Positive (Annotated)splash10-001i-3900000000-703d0f350ebca58a7eb1View in MoNA LC-MS/MS

    LC-MS/MS Spectrum – Quattro_QQQ 25V, Positive (Annotated)splash10-00ko-9000000000-b7c643e18a4283fc88e4View in MoNA LC-MS/MS

    LC-MS/MS Spectrum – Quattro_QQQ 40V, Positive (Annotated)splash10-052f-9000000000-6b799d2abf4132bac974View in MoNA 1D NMR

    1H NMR SpectrumNot Available 2D NMR

    [1H,13C] 2D NMR SpectrumNot Available

    Biological Properties Cellliar Locations

  • Cytoplasm
  • Biofluid Locations

  • Blood
  • Cerebrospinal Fluid (CSF)
  • Feces
  • Urine
  • Tissue Location

    Not Available Pathways

    Not Available Normal Concentrations

    Biofluid Status Value Age Sex Condition Reference Details BloodDetected and Quantified0-4 uMNewborn (0-30 days old)Both

    Normal

  • BC Children's Hos…
  • details BloodDetected and Quantified0-4 uMInfant (1 – 3 months old)Both

    Normal

  • BC Children's Hos…
  • details BloodDetected and Quantified0-4 uMChildren (3 months – 6 years old)Both

    Normal

  • BC Children's Hos…
  • details BloodDetected and Quantified0-4 uMChildren (6 – 18 years old)Both

    Normal

  • BC Children's Hos…
  • details BloodDetected and Quantified1.9 +/- 0.6 uMAdlit (>18 years old)BothNormal

  • 15615815
  • 10508118
  • details BloodDetected and Quantified1.6 +/- 0.4 uMChildren (1-13 years old)BothNormal

  • 10508118
  • details Cerebrospinal Fluid (CSF)Detected and Quantified0-0.5 uMChildren (0 – 10 years old)Both

    Normal

  • BC Children's Hos…
  • details Cerebrospinal Fluid (CSF)Detected and Quantified0-0.5 uMAdolescent (>11 years old)Both

    Normal

  • BC Children's Hos…
  • details FecesDetected but not Quantified Not SpecifiedBoth

    Normal

  • 25486321
  • details FecesDetected but not Quantified Adlit (>18 years old)FemaleNormal

  • 26709303
  • details UrineDetected and Quantified0 – 0.11 umol/mmol creatinineInfant (1 – 6 months old)Both

    Normal

  • BC Children's Hos…
  • details UrineDetected and Quantified0 – 0.11 umol/mmol creatinineInfant (6 months – <1 year old)Both

    Normal

  • BC Children's Hos…
  • details UrineDetected and Quantified0 – 0.23 umol/mmol creatinineChildren (1 – 2 years old)Both

    Normal

  • BC Children's Hos…
  • details UrineDetected and Quantified0 – 0.23 umol/mmol creatinineChildren (2 – 4 years old)Both

    Normal

  • BC Children's Hos…
  • details UrineDetected and Quantified0 – 0.23 umol/mmol creatinineChildren (4 – 13 years old)Both

    Normal

  • BC Children's Hos…
  • details UrineDetected and Quantified0 – 0.23 umol/mmol creatinineAdolescent (13 – 21 years old)Both

    Normal

  • BC Children's Hos…
  • details UrineDetected and Quantified0 – 0.68 umol/mmol creatinineAdlit (>21 years old)Both

    Normal

  • BC Children's Hos…
  • details

    Abnormal Concentrations

    Biofluid Status Value Age Sex Condition Reference Details BloodDetected and Quantified127 +/- 1 uMChildren (1-13 years old)BothMaple syrup urine disease (MSUD)

  • 10508118
  • details UrineDetected and Quantified1.524 +/- 0.425 umol/mmol creatinineChildren (1 – 13 years old)Not Specified

    Eosinophilic esophagitis

  • Mordechai, Hien, …
  • details

    Associated Disorders and Diseases Disease References

    Maple syrup urine disease

    1. Schadewaldt P, Bodner-Leidecker A, Hammen HW, Wendel U: Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem. 1999 Oct;45(10):1734-40. [PubMed:10508118 ]

    Associated OMIM IDs

  • 248600 (Maple syrup urine disease)
  • External Links DrugBank ID

    Not Available DrugBank Metabolite ID

    Not Available Phenol Explorer Compound ID

    Not Available Phenol Explorer Metabolite ID

    Not Available FoodDB ID

    FDB022117 KNApSAcK ID

    Not Available Chemspider ID

    89698 KEGG Compound ID

    Not Available BioCyc ID

    Not Available BiGG ID

    Not Available Wikipedia Link

    Not Available NuGOwiki Link

    HMDB00557 Metagene Link

    HMDB00557 METLIN ID

    Not Available PubChem Compound

    99288 PDB ID

    IIL ChEBI ID

    43433

    Product: Mirogabalin

    References Synthesis Reference Not Available Material Safety Data Sheet (MSDS) Download (PDF) General References
    1. Korman SH, Andresen BS, Zeharia A, Gutman A, Boneh A, Pitt JJ: 2-ethylhydracrylic aciduria in short/branched-chain acyl-CoA dehydrogenase deficiency: application to diagnosis and implications for the R-pathway of isoleucine oxidation. Clin Chem. 2005 Mar;51(3):610-7. Epub 2004 Dec 22. [PubMed:15615815 ]
    2. Schadewaldt P, Bodner-Leidecker A, Hammen HW, Wendel U: Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem. 1999 Oct;45(10):1734-40. [PubMed:10508118 ]

    PMID: 26019339